Rankings
▼
Calendar
BHVN
Biohaven Ltd.
$1B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$219M
Net Income
-$214M
EPS (Diluted)
$-5.97
Cash Flow
Operating Cash Flow
-$146M
Free Cash Flow
-$147M
Stock-Based Comp.
$66M
Balance Sheet
Total Assets
$142M
Total Liabilities
$47M
Stockholders' Equity
$35M
Cash & Equivalents
$76M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$219M
-$115M
-91.2%
Net Income
-$214M
-$119M
-80.2%
← Q4 2020
All Quarters
Q1 2021 →
BHVN FY 2021 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena